Scott Bizily, Chief Legal Officer at 4D Molecular Therapeutics, sold FDMT on Sep 16, 2026
Data as of Oct 16
▼ SELL$22.3K1,635 shares at $13.65Scott Bizily Chief Legal OfficerFDMT 4D Molecular Therapeutics, Inc.
- Traded
- Sep 16, 2026
- Disclosed
- Sep 22, 2026
- Filed
- 6 days after the trade · late
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
FDMT since disclosure
−23.6%
after the sale
Similar stocks (XLV) since disclosure
+4.0%
XLV — its sector index fund
Change in closing price from Sep 22, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.